Seasonal allergic rhinitis: modern aspects of diagnosis and treatment


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The prevalence of allergic rhinitis (AR) in Russia is about 24%. In addition to nasal and ocular symptoms, patients note a significant impact on performance capability and quality of life. Modern diagnosis of seasonal AR includes skin tests, determination of specific IgE antibodies, nasal provocation test with allergens and requires the participation of an allergist. Pharmacotherapy allows to achieve symptom control and improve the quality of life, the key role is played by intranasal glucocorticosteroids.

全文:

受限制的访问

作者简介

E. Pchelenok

Russian Medical Academy of Continuous Professional Education

Department of Pharmacology and Clinical Pharmacology Moscow, Russia

O. Tarasova

Russian Medical Academy of Continuous Professional Education

Department of Pharmacology and Clinical Pharmacology Moscow, Russia

S. Kosyakov

Russian Medical Academy of Continuous Professional Education

Department of Pharmacology and Clinical Pharmacology Moscow, Russia

A. Vinnikov

Russian Medical Academy of Continuous Professional Education

Department of Pharmacology and Clinical Pharmacology Moscow, Russia

参考

  1. Dykewicz M.S., Wallace D.V., Baroody F., et al. Treatment of seasonal allergic rhinitis: an evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol. 2017;119(6):489-511. doi: 10.1016/j.anai.2017.08.012.
  2. Emeryk A, Emeryk-Maksymiuk J., Janeczek K. New guidelines for the treatment of seasonal allergic rhinitis. Adv Dermatol Allergol. 2019;XXXVI(3):255-60. Doi: 10.5114/ ada.2018.75749.
  3. Leung A.K., Hon K.L. Seasonal Allergic Rhinitis. Recent. Pat. Inflamm. Allergy Drug Discov. 2008;2(3):175-85. doi: 10.2174/187221308786241965.
  4. Хаитов М.Р, Намазова-Баранова Л.С., Ильина Н.И. и др. ARIA 2019: алгоритмы оказания помощи при аллергическом рините в России. Российский аллергологический журнал. 2020;17(1):7-22. @@Khaitov M.R., Namazova-Baranova L.S., Ilyina N.I. ARIA 2019: Allergic Rhinitis Care Algorithms in Russia. Rossiiskii allergologicheskii zhurnal. 2020;17(1):7-22. (In Russ.). doi: 10.36691/RAJ.2020.17.1.001.
  5. Mahr T.A, Sheth K. Update on allergic rhinitis. Pediatr Rev. 2005;26:278-82.
  6. Corren J. Allergic rhinitis and asthma: How important is the link? J Allergy Clin Immunol. 1997;99:S781-86.
  7. Терехова Е.П., Ненашева Н.М., Осипова Г.Л., Терехов Д.В. Поллиноз: выбор антигистаминного препарата. Эффективная фармакотерапия. 2019;15(15):34-45. @@Terekhova E.P, Nenasheva N.M., Osipova G.L., Terekhov D.V Hay fever: choice of antihistamine drug. Effektivnaya farmakoterapiya. 2019;15(15):34-45 (In Russ.). doi: 10.33978/2307-3586-2019-15-15-34-45.
  8. Старостина С.В., Толданов А.В. Использование интраназальных кортикостероидов у пациентов с аллергическим ринитом. Consilium Medicum. 2021;23(12):950-55. @@Starostina S.V., Toldanov A.V. Use of intranasal corticosteroids in patients with allergic rhinitis. Consilium Medicum. 2021;23(12):950-55. (In Russ.). Doi: 10.2644 2/20751753.2021.12.201301.
  9. Себекина О.В., Передкова Е.В., Ненашева Н.М. Снижение медикаментозной нагрузки при аллергическом рините. Эффективная фармакотерапия. 2020;16(8):24-30. doi: 10.33978/2307-3586-2020-16-8-24-30.
  10. Hashiguchi K., Wakabayashi K., Togawa M., et al. Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber). Allergol Int. 2017;66(1):123-doi: 10.1016/j.alit.2016.06.009.
  11. Klimek L., Sperl A., Becker S., et al. Current therapeutical strategies for allergic rhinitis. Expert Opin Pharmacother 2019;20(1):83-9. doi: 10.1080/14656566.2018.1543401.
  12. Daley-Yates P.T., Larenas-Linnemann D., Bhargave C., et al.Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index. J Asthma Allergy. 2021;14:1093-104. doi: 10.2147/JAA. S321332.
  13. Hellgren J., Cervin A., Nordling S., et al. Allergic rhinitis and the common cold--high cost to society. Allergy. 2010;65(6):776-83. doi: 10.1111/j.1398-9995.2009.02269.x.
  14. Esmailpour N., Hogger P., Rohdewald P Binding of glucocorticoids to human nasal tissue in vitro.Int Arch Allergy Immunol. 2000;122(2):151-54.doi: 10.1159/000024371.
  15. Baumann D., Bachert C., Hogger P. Dissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex vivo. Clin. Exp. Allergy. 2009;39(10):1540-50. doi: 10.1111/j.1365-2222.2009.03306.x.
  16. van Cauwenberge P., Van Hoecke H., Vandenbulcke L., et al. Glucocorticosteroids in allergic inflammation: clinical benefits in allergic rhinitis, rhinosinusitis, and otitis media. Immunol. Allergy Clin. North Am. 2005;25(3):489-509. doi: 10.1016/j.iac.2005.05.001.
  17. Herman H. Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost. Am J Rhinol. 2007;21(1):70-9. doi: 10.2500/ajr.2007.21.2896.
  18. Nielsen L.P., Mygind N., Dahl R.Intranasal corticosteroids for allergic rhinitis: superior relief? Drugs. 2001;61(11):1563-79. doi: 10.2165/00003495-200161110-00004.
  19. Daley-Yates P.T., Kunka R.L., Yin Y., et al. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays. Eur J Clin Pharmacol. 2004;60(4):265-68. doi: 10.1007/s00228-004-0763-y.
  20. Daley-Yates P.T., Baker R.C. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations. Br J Clin Pharmacol. 2001;51(1):103-5. doi: 10.1046/j.1365-2125.2001.01325.x.
  21. Lagos J.A., Marshall G.D. Montelukast in the management of allergic rhinitis. Ther Clin Risk Manag. 2007;3(2):327-32. Doi: 10.2147/ tcrm.2007.3.2.327.
  22. Kopp M.V, Hamelmann E., Zielen S., et al.Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and comorbid seasonal allergic asthma. Clin Exp Allergy. 2009;39(2):271-79. doi: 10.1111/j.1365-2222.2008.03121.x.
  23. Smart B.A. The impact of allergic and nonallergic rhinitis on pediatric sinusitis. Curr Allergy Asthma Rep. 2006;6:221-27. doi: 10.1007/s11882-006-0038-z.
  24. Calderon M.A., Alves B., Jacobson M., et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev. 2007;1:CD001936. doi: 10.1002/14651858. CD001936.pub2.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##